All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. - Wikidata - wikimedia - TriplyDB

All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.

All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.

http://www.wikidata.org/entity/Q34155766

about

The role of maintenance therapy in acute promyelocytic leukemia in the first complete remission The role of maintenance therapy in acute promyelocytic leukemia in first complete remission Arsenic trioxide for the treatment of acute promyelocytic leukaemia Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Le A review of arsenic trioxide and acute promyelocytic leukemia Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells Hematological remission and long term hematological control of acute myeloblastic leukemia induced and maintained by granulocyte-colony stimulating factor (G-CSF) therapy.Differentiation therapy of leukemia: 3 decades of development.Curing all patients with acute promyelocytic leukemia: are we there yet?Maintenance therapy with all-trans retinoic acid and arsenic trioxide improves relapse-free survival in adults with low- to intermediate-risk acute promyelocytic leukemia who have achieved complete remission after consolidation therapy.Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemia Acute promyelocytic leukemia with a cryptic insertion of RARA into PML on chromosome 15 due to uniparental isodisomy: A case report.Retinoic Acid affects Lung Adenocarcinoma growth by inducing differentiation via GATA6 activation and EGFR and Wnt inhibition Outcomes for children and adolescents with cancer: challenges for the twenty-first century.Inhibition of mitotic kinase Aurora suppresses Akt-1 activation and induces apoptotic cell death in all-trans retinoid acid-resistant acute promyelocytic leukemia cells Outcomes in patients with relapsed or refractory acute promyelocytic leukemia treated with or without autologous or allogeneic hematopoietic stem cell transplantation ATO/ATRA/anthracycline-chemotherapy sequential consolidation achieves long-term efficacy in primary acute promyelocytic leukemia.Acute myeloid leukemia, version 2.2013.The Biology and Targeting of FLT3 in Pediatric Leukemia.All-trans retinoic acid and late relapses in acute promyelocytic leukemia: very long-term follow-up of the North American Intergroup Study I0129.Acute promyelocytic leukemia: a population-based study on incidence and survival in the United States, 1975-2008.Dynamics of leukemia stem-like cell extinction in acute promyelocytic leukemia.Olfactomedin 4 is a novel target gene of retinoic acids and 5-aza-2'-deoxycytidine involved in human myeloid leukemia cell growth, differentiation, and apoptosis.Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia Clinical characteristics, outcome and early induction deaths in patients with acute promyelocytic leukaemia: a five-year experience at a tertiary care centre MicroRNA-27a Contributes to Rhabdomyosarcoma Cell Proliferation by Suppressing RARA and RXRA.Top five medical innovations in China mainland since Xinhai revolution [1911]: results of AME survey-002.Acute promyelocytic leukemia: an experience on 95 greek patients treated in the all-trans-retinoic Acid era Newly diagnosed acute promyelocytic leukemia Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia Budgetary impact of treating acute promyelocytic leukemia patients with first-line arsenic trioxide and retinoic acid from an Italian payer perspective.All-trans-retinoic acid ameliorated high fat diet-induced atherosclerosis in rabbits by inhibiting platelet activation and inflammation.A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia Addition of Arsenic Trioxide into Induction Regimens Could Not Accelerate Recovery of Abnormality of Coagulation and Fibrinolysis in Patients with Acute Promyelocytic Leukemia Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia All-Trans Retinoic Acid-Induced Pseudotumor Cerebri during Induction Therapy for Acute Promyelocytic Leukemia: A Case Report and Literature Review Unfavorable neuroblastoma prognostic factor NLRR2 inhibits cell differentiation by transcriptional induction through JNK pathway Solid tumor differentiation therapy - is it possible?

P2860

Q24200224-7CF60E37-0F6B-4950-8264-C30221796375 Q24203970-24138BE7-315E-4619-A9A6-76946D0B649A Q24239914-3438E083-6036-4F6F-BD56-BDE01F5FDF98 Q27851641-85203C97-3C37-4E01-8A97-50AD2391500C Q27853031-C32EBC65-481F-4821-8073-D4B17017ADD7 Q28087768-D0CFC2A1-A16D-4711-8BA5-4930E9D6E160 Q28274733-113ABCF8-3BBE-4BD2-9DCB-4747823C8516 Q33359524-31366F6C-1767-437C-B0BD-75285965DA30 Q33409795-DF1919F1-37C5-4957-BA0E-3E57E2AE9B59 Q33613426-2A4D0C53-5303-4C17-832E-F3FEB659B809 Q33631350-059A9DBA-FE19-4E65-BF1A-C282BF0C67EE Q33710730-CB561B9C-755F-46A4-B6AE-1F13E6E42BCE Q33751316-BFAE4074-2F65-42F2-A8B1-F30A4124A91F Q33881153-010D0397-2E28-4C19-B0E9-A5FDA09C3F96 Q33897659-83470F87-2287-4B0A-8579-194F3BDF9B6C Q33907178-3DBA9A79-7A70-4DC7-9140-3CE3F3369135 Q33956085-6693E946-7E97-4211-B126-CA077CABA63D Q34046794-FD357561-F156-4581-A7C5-B13FABABCF43 Q34165330-E96DA1FB-465B-47FD-95EF-3867B97426CD Q34229555-94C5A475-E0C1-40C5-839A-5475323FA084 Q34240112-5858A8DC-CB92-45B1-BAA2-86145D922288 Q34267886-B3901291-30EC-42F4-A0BF-E513237E2F2C Q34287738-5CB6319D-0812-4719-8A0D-FDAE5C0E1B78 Q34450695-5420E7EC-F089-4E11-A38F-B3D75660D103 Q34541742-9D8272CC-E771-45E5-987C-44724D650F27 Q34546653-F57E71C5-B5F8-4497-9833-204428D516A4 Q34953881-ECBDCDEF-C375-4FBA-A979-010609C2393D Q35542078-2BB628F1-48C7-4C5F-914C-1B9AAB43679E Q35589141-7A23CAAE-9B05-4A16-8FF8-67CC48F039F9 Q35640734-FC5B2B2B-D508-4E28-A247-83FB5CA05667 Q35640773-25489CD5-0DDB-45CF-B9E1-DC8FCBA38DAB Q35717816-4053F00E-D8FD-4EE0-ABA3-CE66FF337616 Q35743980-D25B5584-B9D4-4D6A-A228-A5DE50854675 Q35830449-1E4F8BA0-B227-4666-B8B5-38378F39C6B4 Q35885317-3DC85F2B-1731-4290-A15F-1407646E8C1F Q35904994-6D07F450-F6C9-4077-94F6-36C7B54C43CE Q35955272-DC7E2B0F-D77C-44D2-B3DE-3584009ED295 Q36021622-2DB95FF1-9747-4DE2-92BC-1E4D6CA93D0F Q36064304-29FD62CD-4FC1-4724-BCF8-E9533A52E935 Q36071880-851E1F93-F516-475F-A43F-DA8ECCA86D7A

P2860

All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.

http://www.wikidata.org/entity/Q34155766

description

2002 nî lūn-bûn

@nan

2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

All-trans retinoic acid in acu ...... American Intergroup protocol.

@ast

All-trans retinoic acid in acu ...... American Intergroup protocol.

@en

All-trans retinoic acid in acu ...... American Intergroup protocol.

@nl

type

label

All-trans retinoic acid in acu ...... American Intergroup protocol.

@ast

All-trans retinoic acid in acu ...... American Intergroup protocol.

@en

All-trans retinoic acid in acu ...... American Intergroup protocol.

@nl

prefLabel

All-trans retinoic acid in acu ...... American Intergroup protocol.

@ast

All-trans retinoic acid in acu ...... American Intergroup protocol.

@en

All-trans retinoic acid in acu ...... American Intergroup protocol.

@nl

P1433

Q34155766-ACC5034A-2973-42FB-B4BC-7489ACE8316D

P1476

Q34155766-3CFBC416-31CA-4F45-9B54-8FD797B9E120

P2093

Q34155766-1402E181-9BCE-4B4F-BD3A-F36064A931DA

Q34155766-16B8D74C-172F-4AAC-8CB4-A6DBBB80D51A

Q34155766-2D2F9404-4927-4931-8219-4F5E74E6B984

Q34155766-4ED1E19E-0299-41DA-B9D8-D7A2F4D33ACD

Q34155766-6BC017A6-4A22-45EB-ABFE-58B5C91D7F39

Q34155766-7612C191-9A2A-412E-9A60-FE18FA740D85

Q34155766-933146B8-5036-463F-B412-7BDF9085BDA4

Q34155766-A24A7E31-8FF4-4F04-8A4D-D688E7A33AFB

Q34155766-F28C2A4A-015B-465C-9505-D32CC574E860

Q34155766-FFB2B2B7-8F57-413A-9CD9-434FCBB56D15

P304

Q34155766-F3B66019-3EC4-4F64-B41A-D82FBF4BBD26

P31

Q34155766-CEE00020-798A-4BB5-8E1A-429A403AEFB6

P356

Q34155766-00395FF7-49BC-425B-91C2-D0EC2DE6DAEF

P407

Q34155766-F3F19EC0-A73E-4FB1-B76A-2208501C318B

P433

Q34155766-9B103C01-7501-43E4-86F3-E1C16015E051

P478

Q34155766-0A691E70-9D52-4F6F-8D8D-F966A6A6F2E0

P50

Q34155766-08B6E46E-91BD-42AA-B302-4FFDF6F98569

Q34155766-5BAC39F3-9A00-4AF7-B30B-01E39625378A

Q34155766-B672C6BB-FD38-4411-8AA7-823788468186

P577

Q34155766-AA79591F-1976-4A24-8E63-F209FCEB4159

P5875

Q34155766-3B05E346-6CC6-4805-AF0B-830B6C2F7C52

P698

Q34155766-C38D1564-F029-45B5-B913-87D0A65CF1E2

P921

Q34155766-128C0756-779D-474B-8A5B-45E8BE112B2A

P356

BLOOD-2002-02-0632

P1433

P1476

All-trans retinoic acid in acu ...... American Intergroup protocol.

@en

P2093

Angela Ogden

http://www.w3.org/2001/XMLSchema#string

Charles A Schiffer

http://www.w3.org/2001/XMLSchema#string

Cheryl Willman

http://www.w3.org/2001/XMLSchema#string

Howard Weinstein

http://www.w3.org/2001/XMLSchema#string

Jacob M Rowe

http://www.w3.org/2001/XMLSchema#string

James H Feusner

http://www.w3.org/2001/XMLSchema#string

Janet W Andersen

http://www.w3.org/2001/XMLSchema#string

Lois Shepherd

http://www.w3.org/2001/XMLSchema#string

Peter H Wiernik

http://www.w3.org/2001/XMLSchema#string

William G Woods

http://www.w3.org/2001/XMLSchema#string

P304

4298-4302

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2002-02-0632

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Clara D. Bloomfield

Martin S Tallman

Frederick R. Appelbaum

P577

2002-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5270998

http://www.w3.org/2001/XMLSchema#string

P698

12393590

http://www.w3.org/2001/XMLSchema#string

P921